← Back to CLDI

Calidi Biotherapeutics, Inc. Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 14/05/2026Sep 2025Filed 13/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 14/05/2026Sep 2024Filed 13/11/2025Jun 2024Filed 08/08/2025Mar 2024Filed 14/05/2025
−$4.2−$4.1−$5.1−$5.7−$5−$5.1−$5.8−$7.2
−$2.94−$0.43−$2.21−$31.75−$2.21−$7.75−$16.75−$2.03
1.4100.22.3

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.